Navigation Links
Celsion Corporation Reports First Quarter 2013 Financial Results and Provides Business Update
Date:5/9/2013

LAWRENCEVILLE, N.J., May 9, 2013 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the first quarter ended March 31, 2013 and provided a business update on its clinical trials of ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin.  ThermoDox® is being evaluated in a global, multi-center Phase III clinical trial (the HEAT Study) in patients with non-resectable hepatocellular carcinoma (HCC), also known as primary liver cancer.  ThermoDox® is also being evaluated in a Phase II trial for patients with recurrent chest wall breast cancer, The DIGNITY Study.

Following the announcement on January 31, 2013, that ThermoDox® in combination with radiofrequency ablation (RFA) did not meet the HEAT Study's primary endpoint, the Company conducted a comprehensive analysis of the data from the Study which was reviewed by its key principal investigators as well as liver cancer and clinical data experts.  These emerging findings from the HEAT Study suggest that RFA dwell time had a positive impact on progression free survival (PFS) and overall survival (OS) in patients treated with ThermoDox® plus RFA when compared to the control group.  This analysis was conducted in a sizable patient subgroup.  These findings will be discussed by two of the HEAT Study's lead investigators at scientific sessions of the World Conference on Interventional Oncology on May 16, 2013. Celsion's lead investigators agree that these are interesting findings which should be further pursued.

"With the support of our medical advisors, we have been working diligently to better understand the clinical data and findings from the Phase III HEAT Study.  Concurrently, we have been taking appropriate measures to position C
'/>"/>

SOURCE Celsion Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Celsion Corporation to Hold First Quarter 2013 Financial Results Conference Call on Thursday, May 9, 2013
2. Celsion Corporation Provides Business Update
3. Todays Research on Celsion, Zogenix, Actavis, and Avanir Pharma
4. Celsion Corporation Announces $15 Million Registered Direct Offering
5. Celladon Corporation and SIRO Clinpharm Announce Presentation at "Statisticians in the Pharmaceutical Industry International Conference"
6. ETEX Corporation announces extended Supply Agreement with Knee Creations, LLC
7. Verenium Corporation to Announce First Quarter 2013 Financial Results
8. EMCO High Voltage Corporation to Exhibit at 61st ASMS Conference on Mass Spectrometry and Allied Topics
9. Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives
10. Techne Corporation Releases Unaudited Third Quarter And Nine Month Fiscal Year 2013 Results
11. Street Named After EMCO High Voltage Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015  Emdeon Inc. ... a definitive agreement to acquire Altegra Health, ... platforms that combine data aggregation and analytics ... to achieve actionable insights and improved management ... Altegra Health,s risk adjustment and quality analytics ...
(Date:7/6/2015)... , June 29, 2015 ... announced the addition of the "Biotechnology for ... Biotechnology for the Non-Biotechnologist, ideal for non-Scientists ... principles, techniques and potential of biotechnology. ... the basic theory, principles, techniques, and potential of ...
(Date:7/6/2015)... July 6, 2015 Navitas, a leading Regulatory Service provider, today ... hub in Bogota, Colombia . Navitas, expansion into ... benefits provided by Colombia , the third largest economy ... Logo - http://photos.prnewswire.com/prnh/20150703/228239LOGO ... US based clients to communicate with Navitas regulatory professionals in close to ...
(Date:7/5/2015)... ... 06, 2015 , ... For many years, metal-on-quartz filters were the industry standard ... as a Varian Cary 4000-7000, a Perkin Elmer 800-1100 or a Shimadzu 3600-3700, these ... used them for their SRM-2031 series going back for many years. Unfortunately, these standards ...
Breaking Biology Technology:Emdeon to Acquire Altegra Health 2Emdeon to Acquire Altegra Health 3Emdeon to Acquire Altegra Health 4Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 2Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 3FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 2FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 3
... - Essential, Structure-Searchable Chemistry Resource Brings New,Compounds ... Elsevier Information Systems GmbH, a subsidiary of ... and medical information,is pleased to announce that, ... will contain more than ten million compounds, ...
... BEIJING and CLAREMONT, Calif., Aug. 14 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech ... for the second quarter of 2007 increased more than,35% ... were 139 times,revenues of just $13,351 for the same ... first half of 2007 were $3,256,000 compared to only,$24,374 ...
... Pressure,BioSciences, Inc. (Nasdaq: PBIO ) today announced that ... as compared to $28,783 for the,same period in 2006. Revenue ... the three months ended June 30, 2007 as compared to ... in revenue from PCT,products and services was the result of ...
Cached Biology Technology:CrossFire Beilstein Database Exceeds Ten Million Compounds 2CrossFire Beilstein Database Exceeds Ten Million Compounds 3Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 2Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 3Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 4Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 5Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 6Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 2Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 3Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 4Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 5Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 6Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 7Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 8
(Date:6/18/2015)... , June 18, 2015 This report analyzes ... by the following Product Segments, which includes Immunoassay Analyzers ... Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. ... Canada , Japan ... , Latin America , and ...
(Date:6/17/2015)... Calif. , June 17, 2015  Synaptics ... human interface solutions, today announced that Xiaomi, one ... the Synaptics ® ClearPad ® family ... display driver integrated circuits (DDICs) for its latest ... By leveraging ClearPad for full in-cell display solutions ...
(Date:6/16/2015)... GOTHENBURG, Sweden , June 16, 2015 ... including all touch fingerprint sensors in the company,s portfolio from ... . Deliveries are planned to mainly take place during the ... manufacturers in Asia . Jörgen ... another evidence of    the   growing interest from smartphone ...
Breaking Biology News(10 mins):Global Immunoassay Systems Market 2Global Immunoassay Systems Market 3Global Immunoassay Systems Market 4Global Immunoassay Systems Market 5Global Immunoassay Systems Market 6Global Immunoassay Systems Market 7Global Immunoassay Systems Market 8Global Immunoassay Systems Market 9Global Immunoassay Systems Market 10Global Immunoassay Systems Market 11Global Immunoassay Systems Market 12Global Immunoassay Systems Market 13Global Immunoassay Systems Market 14Global Immunoassay Systems Market 15Global Immunoassay Systems Market 16Global Immunoassay Systems Market 17Global Immunoassay Systems Market 18Global Immunoassay Systems Market 19Global Immunoassay Systems Market 20Global Immunoassay Systems Market 21Global Immunoassay Systems Market 22Global Immunoassay Systems Market 23Global Immunoassay Systems Market 24Global Immunoassay Systems Market 25Global Immunoassay Systems Market 26Global Immunoassay Systems Market 27Global Immunoassay Systems Market 28Global Immunoassay Systems Market 29Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2
... new study of transfer RNA, a molecule that delivers amino ... ideas about the evolutionary history of protein synthesis., In the ... (reading the genetic blueprint for a protein, and adding a ... appear to have originated independently of one another. The new ...
... a devastating new wheat disease strain which could lead to ... in the United States, with funding from the Bill & ... undertake the research as part of the Durable Rust Resistance ... the fungus, wheat stem rust. World leaders in rust ...
... has been honored for his role in the development ... who suffer severe, life-threatening injuries in Iraq and Afghanistan. ... for Combat Casualty Care Award was presented to Stucky ... annual meeting in Florida. The ATACCC convention is the ...
Cached Biology News:Study reveals surprising details of the evolution of protein translation 2CSIRO enlisted to avert global wheat supply crisis 2UCSB chemistry professor receives top military award for life-saving gauze 2UCSB chemistry professor receives top military award for life-saving gauze 3